| Literature DB >> 8801163 |
C Chomienne1, P Fenaux, L Degos.
Abstract
Acute promyelocytic leukemia (APL) is a specific type of acute myeloid leukemia characterized by the morphology of the blast cells, a specific t(15;17) translocation, and risks of definite coagulopathy. Recently this leukemia was further characterized by an exquisite sensitivity to all-trans retinoic acid's differentiation effect and the production of a fusion gene altering the gene of RARalpha and a novel gene PML. In vivo differentiation therapy with retinoids in APL patients follows strict guidelines related both to the APL cell and the biodisposal of all-trans retinoic acid.Entities:
Mesh:
Substances:
Year: 1996 PMID: 8801163 DOI: 10.1096/fasebj.10.9.8801163
Source DB: PubMed Journal: FASEB J ISSN: 0892-6638 Impact factor: 5.191